Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 206

Similar articles for PubMed (Select 15858013)

1.

New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.

Taylor DR, Puig M, Darnell ME, Mihalik K, Feinstone SM.

J Virol. 2005 May;79(10):6291-8.

2.

Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.

Chang JH, Kato N, Muroyama R, Taniguchi H, Guleng B, Dharel N, Shao RX, Tateishi K, Jazag A, Kawabe T, Omata M.

Liver Int. 2010 Feb;30(2):311-8. doi: 10.1111/j.1478-3231.2009.02144.x. Epub 2009 Oct 16.

PMID:
19840259
3.

Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.

Jia Y, Wei L, Jiang D, Wang J, Cong X, Fei R.

J Gastroenterol Hepatol. 2007 Aug;22(8):1278-85. Epub 2007 Jun 12.

PMID:
17565587
4.

[Investigating the inhibitory effects of interferon-alpha on the replication of hepatitis C virus replicon].

Jia YT, Wei L, Jiang D, Cong X, Fei R.

Zhonghua Yi Xue Za Zhi. 2005 Aug 3;85(29):2065-9. Chinese.

PMID:
16313804
5.

Replication studies using genotype 1a subgenomic hepatitis C virus replicons.

Gu B, Gates AT, Isken O, Behrens SE, Sarisky RT.

J Virol. 2003 May;77(9):5352-9.

6.

Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system.

Escuret V, Martin A, Durantel D, Parent R, Hantz O, Trépo C, Menguy T, Bottius E, Dardy J, Maral J, Escary JL, Zoulim F.

Antimicrob Agents Chemother. 2006 Dec;50(12):3984-91. Epub 2006 Oct 9.

7.

Discovery and characterization of substituted diphenyl heterocyclic compounds as potent and selective inhibitors of hepatitis C virus replication.

Huang P, Goff DA, Huang Q, Martinez A, Xu X, Crowder S, Issakani SD, Anderson E, Sheng N, Achacoso P, Yen A, Kinsella T, Darwish IS, Kolluri R, Hong H, Qu K, Stauffer E, Goldstein E, Singh R, Payan DG, Lu HH.

Antimicrob Agents Chemother. 2008 Apr;52(4):1419-29. doi: 10.1128/AAC.00525-07. Epub 2008 Jan 28.

8.

Effect of alpha interferon on the hepatitis C virus replicon.

Guo JT, Bichko VV, Seeger C.

J Virol. 2001 Sep;75(18):8516-23.

9.

Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway.

Frese M, Pietschmann T, Moradpour D, Haller O, Bartenschlager R.

J Gen Virol. 2001 Apr;82(Pt 4):723-33.

10.

Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.

Liu WL, Su WC, Cheng CW, Hwang LH, Wang CC, Chen HL, Chen DS, Lai MY.

J Infect Dis. 2007 Aug 1;196(3):425-34. Epub 2007 Jun 25.

11.

The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon.

Hayashi J, Stoyanova R, Seeger C.

Virology. 2005 May 10;335(2):264-75.

12.

Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.

Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C.

Hepatology. 2003 May;37(5):1180-8.

PMID:
12717400
13.

The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells.

Hartwig D, Schütte C, Warnecke J, Dorn I, Hennig H, Kirchner H, Schlenke P.

J Viral Hepat. 2006 Mar;13(3):150-7.

PMID:
16475990
14.

Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.

Tanabe Y, Sakamoto N, Enomoto N, Kurosaki M, Ueda E, Maekawa S, Yamashiro T, Nakagawa M, Chen CH, Kanazawa N, Kakinuma S, Watanabe M.

J Infect Dis. 2004 Apr 1;189(7):1129-39. Epub 2004 Mar 16.

15.

Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype.

Namba K, Naka K, Dansako H, Nozaki A, Ikeda M, Shiratori Y, Shimotohno K, Kato N.

Biochem Biophys Res Commun. 2004 Oct 8;323(1):299-309.

PMID:
15351737
16.

Mechanism of the interferon alpha response against hepatitis C virus replicons.

Guo JT, Sohn JA, Zhu Q, Seeger C.

Virology. 2004 Jul 20;325(1):71-81.

PMID:
15231387
17.

Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.

Zhang T, Lin RT, Li Y, Douglas SD, Maxcey C, Ho C, Lai JP, Wang YJ, Wan Q, Ho WZ.

Hepatology. 2005 Oct;42(4):819-27.

PMID:
16175599
18.

Interferon-alpha and ribavirin resistance of Huh7 cells transfected with HCV subgenomic replicon.

Aus dem Siepen M, Oniangue-Ndza C, Wiese M, Ross S, Roggendorf M, Viazov S.

Virus Res. 2007 Apr;125(1):109-13. Epub 2007 Jan 24.

PMID:
17254660
19.

PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone.

Rivas-Estilla AM, Svitkin Y, Lopez Lastra M, Hatzoglou M, Sherker A, Koromilas AE.

J Virol. 2002 Nov;76(21):10637-53.

20.

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.

Zhu H, Butera M, Nelson DR, Liu C.

Virol J. 2005 Sep 7;2:80.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk